HDAC4 and acute kidney injury: To investigate the pharmacological effect of HDAC4 inhibition on the IR-induced AKI, we treated the mouse model of AKI with/without tasquinimod, a selective HDAC4 inhibitor, immediately after reperfusion (Figure S2B).